Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.27 - $3.02 $113,500 - $151,000
50,000 New
50,000 $116,000
Q4 2023

Feb 14, 2024

BUY
$1.72 - $2.19 $189,200 - $240,900
110,000 New
110,000 $229,000
Q2 2023

Aug 14, 2023

SELL
$1.67 - $2.04 $334,000 - $408,000
-200,000 Reduced 66.67%
100,000 $197,000
Q1 2023

May 15, 2023

BUY
$1.87 - $2.6 $140,250 - $195,000
75,000 Added 33.33%
300,000 $582,000
Q4 2022

Feb 14, 2023

BUY
$2.49 - $3.5 $249,000 - $350,000
100,000 Added 80.0%
225,000 $571,000
Q3 2022

Nov 14, 2022

SELL
$2.82 - $3.58 $70,500 - $89,500
-25,000 Reduced 16.67%
125,000 $352,000
Q2 2022

Aug 15, 2022

BUY
$2.59 - $3.92 $129,500 - $196,000
50,000 Added 50.0%
150,000 $419,000
Q1 2022

May 16, 2022

SELL
$3.0 - $4.25 $105,000 - $148,750
-35,000 Reduced 25.93%
100,000 $389,000
Q4 2021

Feb 14, 2022

BUY
$3.85 - $6.71 $519,750 - $905,850
135,000 New
135,000 $532,000
Q4 2020

Feb 16, 2021

SELL
$5.0 - $8.85 $250,000 - $442,500
-50,000 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$4.96 - $7.08 $248,000 - $354,000
50,000 New
50,000 $250,000
Q2 2020

Aug 14, 2020

SELL
$4.84 - $8.02 $2.29 Million - $3.8 Million
-473,201 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$4.52 - $8.55 $3.68 Million - $6.97 Million
-815,200 Reduced 63.27%
473,201 $3.75 Million
Q4 2019

Feb 14, 2020

BUY
$6.14 - $9.3 $7.91 Million - $12 Million
1,288,401 New
1,288,401 $12.7 Million
Q4 2018

Feb 14, 2019

SELL
$6.8 - $12.88 $1.53 Million - $2.9 Million
-225,000 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$5.65 - $13.75 $988,750 - $2.41 Million
175,000 Added 350.0%
225,000 $2.5 Million
Q2 2018

Aug 14, 2018

BUY
$5.52 - $7.93 $98,719 - $141,820
17,884 Added 55.69%
50,000 $326,000
Q1 2018

May 15, 2018

BUY
$5.51 - $10.97 $176,959 - $352,312
32,116 New
32,116 $216,000

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $760M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Polar Asset Management Partners Inc. Portfolio

Follow Polar Asset Management Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Polar Asset Management Partners Inc. with notifications on news.